BioWorld Asia

Dec. 24, 2003

NeuroSearch Guaranteed EUR82M In GlaxoSmithKline CNS Pact

Danish drug development firm NeuroSearch A/S and GlaxoSmithKline plc entered an alliance focused on the major diseases of the central nervous system. (BioWorld International Read More

Gyros Raises SEK145M To Grow CD-Based Microfluidics Platform

Red Cell Protein Holds Clue To New Malaria Vaccines, Therapies

Picking Up Steam, New Vernalis Signs Cancer Deal With Novartis

Novagali Launches Phase I Trial, Negotiates Second-Round Funds

European Union Agrees On New Framework For Pharmaceuticals

UroGene, SGX To Develop Kinase Inhibitors For Urological Cancers

EU Generally Accepting Of New Rules For Tissues, Cells

Galapagos, Bayer Agree On Deal Using SilenceSelect Technology

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 29, 2026.

Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

ENCALS 2026: From genetics to advancing strategies against ALS

BioWorld Science

Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...

Next wave of BCI firms builds on pioneers to tackle challenges

BioWorld

With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...

Boehringer Ingelheim identifies new mGlu3 receptor agonists

BioWorld Science

Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...

GT-02897 exerts efficacy in preclinical multiple myeloma

BioWorld Science

Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...